| Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a … ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ... The lancet oncology 15 (7), 700-712, 2014 | 1609 | 2014 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 530 | 2018 |
| Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label … K Fizazi, S Foulon, J Carles, G Roubaud, R McDermott, A Fléchon, ... The Lancet 399 (10336), 1695-1707, 2022 | 455 | 2022 |
| Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature P Ost, A Bossi, K Decaestecker, G De Meerleer, G Giannarini, RJ Karnes, ... European urology 67 (5), 852-863, 2015 | 388 | 2015 |
| Oral relugolix for androgen-deprivation therapy in advanced prostate cancer ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ... New England Journal of Medicine 382 (23), 2187-2196, 2020 | 386 | 2020 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 380 | 2020 |
| Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature L Budäus, M Bolla, A Bossi, C Cozzarini, J Crook, A Widmark, T Wiegel European urology 61 (1), 112-127, 2012 | 348 | 2012 |
| Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group P Poortmans, A Bossi, K Vandeputte, M Bosset, R Miralbell, P Maingon, ... Radiotherapy and Oncology 84 (2), 121-127, 2007 | 340 | 2007 |
| Radiotherapy for renal-cell carcinoma G De Meerleer, V Khoo, B Escudier, S Joniau, A Bossi, P Ost, A Briganti, ... The Lancet Oncology 15 (4), e170-e177, 2014 | 311 | 2014 |
| Brachytherapy: An overview for clinicians C Chargari, E Deutsch, P Blanchard, S Gouy, H Martelli, F Guérin, ... CA: a cancer journal for clinicians 69 (5), 386-401, 2019 | 285 | 2019 |
| EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international … TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ... European urology 76 (6), 790-813, 2019 | 235 | 2019 |
| ESTRO ACROP consensus guideline on CT-and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer C Salembier, G Villeirs, B De Bari, P Hoskin, BR Pieters, M Van Vulpen, ... Radiotherapy and Oncology 127 (1), 49-61, 2018 | 215 | 2018 |
| Guidelines for primary radiotherapy of patients with prostate cancer D Boehmer, P Maingon, P Poortmans, MH Baron, R Miralbell, ... Radiotherapy and oncology 79 (3), 259-269, 2006 | 205 | 2006 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 188 | 2020 |
| High-risk prostate cancer: from definition to contemporary management PJ Bastian, SA Boorjian, A Bossi, A Briganti, A Heidenreich, SJ Freedland, ... European urology 61 (6), 1096-1106, 2012 | 172 | 2012 |
| Photophysical properties of cyclometalated pt (II) complexes: counterintuitive blue shift in emission with an expanded ligand π system A Bossi, AF Rausch, MJ Leitl, R Czerwieniec, MT Whited, PI Djurovich, ... Inorganic Chemistry 52 (21), 12403-12415, 2013 | 163 | 2013 |
| Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N-or NX) R de Crevoisier, K Slimane, N Sanfilippo, A Bossi, M Albano, I Dumas, ... International Journal of Radiation Oncology* Biology* Physics 74 (4), 1150-1156, 2009 | 157 | 2009 |
| A systematic review of hypofractionation for primary management of prostate cancer BF Koontz, A Bossi, C Cozzarini, T Wiegel, A D’Amico European urology 68 (4), 683-691, 2015 | 149 | 2015 |
| Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic CJD Wallis, G Novara, L Marandino, A Bex, AM Kamat, RJ Karnes, ... European urology 78 (1), 29-42, 2020 | 145 | 2020 |
| Final analysis of the ipilimumab versus placebo following radiotherapy phase III trial in postdocetaxel metastatic castration-resistant prostate cancer identifies an excess of … K Fizazi, CG Drake, TM Beer, ED Kwon, HI Scher, WR Gerritsen, A Bossi, ... European urology 78 (6), 822-830, 2020 | 143 | 2020 |
